chr2-28865107-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000306108.10(TRMT61B):āc.712A>Gā(p.Ile238Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000187 in 1,600,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000306108.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRMT61B | NM_017910.4 | c.712A>G | p.Ile238Val | missense_variant | 2/7 | ENST00000306108.10 | NP_060380.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRMT61B | ENST00000306108.10 | c.712A>G | p.Ile238Val | missense_variant | 2/7 | 1 | NM_017910.4 | ENSP00000302801.5 | ||
TRMT61B | ENST00000439947.1 | n.712A>G | non_coding_transcript_exon_variant | 2/6 | 5 | ENSP00000389617.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249984Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135154
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1448826Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 721764
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.712A>G (p.I238V) alteration is located in exon 2 (coding exon 2) of the TRMT61B gene. This alteration results from a A to G substitution at nucleotide position 712, causing the isoleucine (I) at amino acid position 238 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at